Evidence map›Paper›PMID 26306037›Full record

ArticleThe Journal of biological chemistry2015

Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes.

Hiromasa Yagi, Paul J Conroy, Eleanor W W Leung, Ruby H P Law, Joseph A Trapani, Ilia Voskoboinik, James C Whisstock, Raymond S Norton

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The C2 domain of calpain 5 contributes to enzyme activation and membrane localization.Biochimica et biophysica acta. Molecular cell research · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Antigen-specific CD8Nature communications · 2017
    Article
  15. Benzenesulphonamide inhibitors of the cytolytic protein perforin.Bioorganic & medicinal chemistry letters · 2017
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hiromasa YagiFrom the Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052.
Paul J Conroythe Department of Biochemistry and Molecular Biology and ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800.
Eleanor W W LeungFrom the Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052.
Ruby H P Lawthe Department of Biochemistry and Molecular Biology and ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800.
Joseph A Trapanithe Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, and the Departments of Microbiology and Immunology and.
Ilia Voskoboinikthe Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, and the Departments of Microbiology and Immunology and Genetics and Pathology, University of Melbourne, Parkville, Victoria 3052, Australia.
James C Whisstockthe Department of Biochemistry and Molecular Biology and ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, james.whisstock@monash.edu.
Raymond S NortonFrom the Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, ray.norton@monash.edu.
Monash University · AUARC Centre of Excellence in Advanced Molecular Imaging · AUPeter MacCallum Cancer Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer cells and cytotoxic T-lymphocytes deploy perforin and granzymes to kill infected host cells. Perforin, secreted by immune cells, binds target membranes to form pores that deliver pro-apoptotic granzymes into the target cell. A crucial first step in this process is interaction of its C2 domain with target cell membranes, which is a calcium-dependent event. Some aspects of this process are understood, but many molecular details remain unclear. To address this, we investigated the mechanism of Ca(2+) and lipid binding to the C2 domain by NMR spectroscopy and x-ray crystallography. Calcium titrations, together with dodecylphosphocholine micelle experiments, confirmed that multiple Ca(2+) ions bind within the calcium-binding regions, activating perforin with respect to membrane binding. We have also determined the affinities of several of these binding sites and have shown that this interaction causes a significant structural rearrangement in CBR1. Thus, it is proposed that Ca(2+) binding at the weakest affinity site triggers changes in the C2 domain that facilitate its interaction with lipid membranes.

Indexed as

Amino Acid SequenceAnimalsCalciumCrystallography, X-RayMembrane LipidsMiceMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularPerforinPhosphorylcholineProtein ConformationSequence Homology, Amino AcidCalciumdodecylphosphocholineMembrane LipidsPerforinPhosphorylcholinecalcium-binding proteincrystal structureimmunologymultisite ligand bindingNMRprotein-membrane interactionx-ray crystallography

Identifiers

PMID26306037
PMCPMC4646173
OpenAlexW1890645185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.